Replacement of intravenous administration of anti-D by subcutaneous administration in patients with autoimmune thrombocytopenia

Pediatric Blood and Cancer

Volumn 47, Issue 5 SUPPL., 2006, Pages 721-722

  Meyer, O ^a   Kiesewetter, H ^a   Hermsen, M ^b   Petriedes, P ^c   Rose, M ^d   Seibt, H ^e   Salama, A ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b EVANGELISCHES KRANKENHAUS   (Germany)

^c Onkologische Praxis   (Germany)

^d KLINIKUM MINDEN   (Germany)

^e Hamatologisch onkologische S   (Germany)

Author keywords

Anti D; ITP; Subcutaneous anti D

Indexed keywords

RHESOGAM; RHESUS D ANTIBODY; RHOPHYLAC;

ADOLESCENT; ADULT; AUTOIMMUNE THROMBOCYTOPENIA; CHILD; CHILL; CLINICAL ARTICLE; DISSEMINATED INTRAVASCULAR CLOTTING; DIZZINESS; DRUG ADMINISTRATION ROUTE; DRUG FATALITY; FEMALE; FEVER; HEADACHE; HEMOLYSIS; HUMAN; HUMAN CELL; MALE; NAUSEA; PRIORITY JOURNAL; REVIEW;

ADULT; CHILD; FEMALE; HEMORRHAGE; HUMANS; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; ISOANTIBODIES; MALE; PLATELET COUNT; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; TREATMENT OUTCOME;

EID: 33748501918     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21006     Document Type: Review

References (11)

1. Salama A, Mueller-Eckhardt C, Kiefel V. Effect of intravenous immunoglobulin in immune thrombocytopenia. Lancet 1983;2:193-195.
2. Salama A, Mueller-Eckhardt C. Use of Rh antibodies in the treatment of autoimmune thrombocytopenia. Transfus Med Rev 1992;6:17-25.
3. Bussel JB, Graziano IN, Kimberly RP, et al. Intravenous anti-D treatment of immune thrombocytopenic purpura: Analysis of efficacy, toxicity, and mechanism of effect. Blood 1991;77:1884-1893.
4. Scaradavou A, Bussel JB. Clinical experience with anti-D in the treatment of idiopathic thrombocytopenic purpura. Semin Hematol 1998;35:52-57.
5. Freiberg A, Mauger D. Efficacy, safety, and dose response of intravenous anti-D immune globulin (WinRho SDF) for the treatment of idiopathic thrombocytopenic purpura in children. Semin Hematol 1998;35:23-27.
6. Blanchette V, Imbach P, Andrew M, et al. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet 1994;344:703-707.
7. Scaradavou A, Woo B, Woloski BM, et al. Intravenous anti-D treatment of immune thrombocytopenic purpura: Experience in 272 patients. Blood 1997;89:2689-2700.
8. Vesely SK, Buchanan GR, Adix L, et al. Self-reported initial management of childhood idiopathic thrombocytopenic purpura: Results of a survey of members of the American Society of Pediatric Hematology/Oncology, 2001. J Pediatr Hematol Oncol 2003;25:130-133.
9. Gaines AR. Acute onset hemoglobinemia and/or hemoglobinuria and sequelae following Rh(o)(D) immune globulin intravenous administration in immune thrombocytopenic purpura patients. Blood 2000;95:2523-2529.
10. Gaines AR. Disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following Rh(0)(D) immune globulin intravenous administration for immune thrombocytopenic purpura. Blood 2005;106:1532-1537.
11. Gardulf A, Andersen V, Bjorkander J, et al. Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: Safety and costs. Lancet 1995;345:365-369.